Jennifer Sue Pitrak Mcdonald

Array ( [id] => 7511541 [patent_doc_number] => 20110257251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'TELOMERASE INHIBITORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/123123 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29484 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257251.pdf [firstpage_image] =>[orig_patent_app_number] => 13123123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626767 [patent_doc_number] => 08796443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Reduced size self-delivering RNAi compounds' [patent_app_type] => utility [patent_app_number] => 13/120342 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 55142 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499415 [patent_doc_number] => 20110262428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'TREATING CANCER BY MODULATING RNA HELICASES' [patent_app_type] => utility [patent_app_number] => 13/120353 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18161 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262428.pdf [firstpage_image] =>[orig_patent_app_number] => 13120353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592855 [patent_doc_number] => 20100048425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'siRNA targeting tumor protein 53 (P53)' [patent_app_type] => utility [patent_app_number] => 12/586271 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30301 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048425.pdf [firstpage_image] =>[orig_patent_app_number] => 12586271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628943 [patent_doc_number] => 09347089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Therapeutic and diagnostic strategies' [patent_app_type] => utility [patent_app_number] => 13/063155 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 43 [patent_no_of_words] => 13656 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448074 [patent_doc_number] => 20100105134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING GENE EXPRESSION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/552082 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 49652 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105134.pdf [firstpage_image] =>[orig_patent_app_number] => 12552082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347934 [patent_doc_number] => 20120208861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'IFN TYPE-I PRODUCTION INHIBITOR AND METHOD FOR SCREENING FOR SAME' [patent_app_type] => utility [patent_app_number] => 13/061426 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13608 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223343 [patent_doc_number] => 20100056612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'MOLECULAR ENTITIES FOR BINDING, STABILIZATION AND CELLULAR DELIVERY OF CHARGED MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/536456 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16183 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056612.pdf [firstpage_image] =>[orig_patent_app_number] => 12536456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575705 [patent_doc_number] => 20100047188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'MODULATION OF TOLL-LIKE RECEPTOR 8 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/534476 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11053 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047188.pdf [firstpage_image] =>[orig_patent_app_number] => 12534476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11178967 [patent_doc_number] => 09410956 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-08-09 [patent_title] => 'Micro-RNA profiling in ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/534618 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 21 [patent_no_of_words] => 9504 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12534618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234779 [patent_doc_number] => 20100186097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'CELL-BASED RNA INTERFERENCE AND RELATED METHODS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/497967 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 18946 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20100186097.pdf [firstpage_image] =>[orig_patent_app_number] => 12497967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10050782 [patent_doc_number] => 09090649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/996362 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19702 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12996362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5949798 [patent_doc_number] => 20110107440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'SKIN CANCER ASSOCIATED MICRORNAS' [patent_app_type] => utility [patent_app_number] => 12/994734 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24131 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20110107440.pdf [firstpage_image] =>[orig_patent_app_number] => 12994734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11560548 [patent_doc_number] => 09623109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Methods of killing cells and use of same in prevention and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/994856 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 109 [patent_no_of_words] => 20187 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227182 [patent_doc_number] => 20120141382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'APTAMER MODULATORS OF COMPLEMENT PROTEIN C3 AND BIOLOGICALLY ACTIVE PROTEOLYTIC PRODUCTS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/469483 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26849 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12469483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551814 [patent_doc_number] => 20090285800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Aberrant expression of CKS1 and CKS2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/454433 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7934 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285800.pdf [firstpage_image] =>[orig_patent_app_number] => 12454433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174378 [patent_doc_number] => 20110177096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'USE OF GPR151 MODULATORS FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 12/993024 [patent_app_country] => US [patent_app_date] => 2009-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5600 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177096.pdf [firstpage_image] =>[orig_patent_app_number] => 12993024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178148 [patent_doc_number] => 20110178159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'INHIBITORY RNAS THAT REGULATE HEMATOPOIETIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/991656 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 21956 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178159.pdf [firstpage_image] =>[orig_patent_app_number] => 12991656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928894 [patent_doc_number] => 20110038853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis' [patent_app_type] => utility [patent_app_number] => 12/988570 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12050 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038853.pdf [firstpage_image] =>[orig_patent_app_number] => 12988570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954512 [patent_doc_number] => 20110034545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'DOUBLE-STRANDED LIPID-MODIFIED RNA HAVING HIGH RNA INTERFERENCE EFFECT' [patent_app_type] => utility [patent_app_number] => 12/935546 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13025 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034545.pdf [firstpage_image] =>[orig_patent_app_number] => 12935546 [rel_patent_id] =>[rel_patent_doc_number] =>)